Is dxcm a long term buy

**Dexcom (DXCM) appears to be a solid long-term investment**. Here's why: 1. **Strong Performance**: Dexcom has shown a significant increase in inventory, with the latest figure reaching $570.3 million. This suggests strong demand for their products, which is a positive indicator for the company's future growth. 2. **Positive Market and Analyst Perception**: The stock has a current price target of $90, with a buy rating from Piper Sandler and a strong buy rating from Stifel. This indicates that analysts are optimistic about the stock's future performance. 3. **Consistent Growth**: The stock has experienced a 68.03% interval percentage change over the past five years, demonstrating a consistent track record of growth. 4. **Market Position**: Dexcom is a leading provider of continuous glucose monitoring systems for people with diabetes, which is a growing and potentially lucrative market. In conclusion, Dexcom shows strong performance, positive market and analyst perception, consistent growth, and a solid market position. These factors combined suggest that DXCM could be a good long-term investment.